Pith. sign in

Paper Citation Record · LEDGER

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials

As of 19 August 2026, this Paper Citation Record lists 19 of 19 outbound references and 0 inbound Pith citation observations for arXiv:2411.16938.

A citation records a reference. It does not transfer a finding from one paper to another.

pith.paper-citation-record.v1
2411.16938 v1

Coverage vector

measured 19 of 19 reference resolution

Typed states for the displayed outbound observations.

Source: paper_references, paper_reference_links, observed 2026-08-12T12:48:30.237887Z

measured 19 of 19 standing notices

One-hop event checks from named stored sources.

Source: scholarly_work_events, retraction_status_cache, observed 2026-08-19T06:32:44.657259+00:00

measured 0 of 0 inbound itemization

Pith citing papers itemized under the disclosed page cap.

Source: paper_references, paper_reference_links

measured 0 of 1 external citation measurements

A source-named dated measurement, never combined with another source.

Source: cited_works

Reference resolution

19 of 19 outbound references displayed

  • verified exact0
  • verified fuzzy19
  • unresolved0
  • parse uncertain0
  • malformed identifier0
  • metadata mismatch0

External citation measurements

No source-named external measurement is stored.

Outbound references

Observation 2f135357-70a6-43ba-9d98-af229a14155e · outbound

This paper cites The use and limitations of the fragility index in the interpretation of clinical trial findings.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials The use and limitations of the fragility index in the interpretation of clinical trial findings

Reference 1

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.755776Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.506416Z digest=sha256:4228635bf27c48b296a308633a49d4a5957e58bf7ee0e178d7cae84350a5bcdc

Observation f1062569-b634-41f8-9acc-d23578323e28 · outbound

This paper cites Fragility indices for only sufficiently likely modifications.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Fragility indices for only sufficiently likely modifications

Reference 2

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.664763Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.525356Z digest=sha256:1b8988917020054019fc4b2b9fe402eec5bcdafe9945b468adf092f051b9c65f

Observation 0525fb96-cc40-4768-b6ec-b844dee4e6c6 · outbound

This paper cites Survival-inferred fragility index of phase 3 clinical trials evaluating immune checkpoint inhibitors.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Survival-inferred fragility index of phase 3 clinical trials evaluating immune checkpoint inhibitors

Reference 3

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.611931Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.556876Z digest=sha256:cd4d85b1452a24a79f15b220dc10f560523f5d924c5add396d30aa49d8f1e275

Observation 8dae6f34-1e72-45a1-baa2-d74f59b3d653 · outbound

This paper cites It's time to talk about ditching statistical significance.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials It's time to talk about ditching statistical significance

Reference 4

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.554765Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.593384Z digest=sha256:0f78753077c1d3322492bce0d00b5b1be163248a9dae67cbab04c757b185b665

Observation 78cb7e2a-dff9-4eeb-ab43-1b3dc66cc245 · outbound

This paper cites Truncated life tests in the exponential case.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Truncated life tests in the exponential case

Reference 5

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.488812Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.613122Z digest=sha256:3889f5a570429cd51deda40a3b0af29cb83adcf1a82f1c4e659b1a2432f9bd7c

Observation 0f4cdaa6-439b-42d9-a85d-bb752b212436 · outbound

This paper cites Life testing.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Life testing

Reference 6

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.429115Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.631900Z digest=sha256:24af01e39e3e8339fa8198ba38a1b1c611332c7451533e49c2fe5025a88aa553

Observation cf995f81-2c52-45de-81ec-303c46782f64 · outbound

This paper cites Some theorems relevant to life testing from an exponential distribution.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Some theorems relevant to life testing from an exponential distribution

Reference 7

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.302352Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.652510Z digest=sha256:ef82a264252ecc0541f38332cec6232fe18314f23dfcd0137878a93a2cbe6347

Observation 946b6a41-3525-4b76-a38a-e0e8797c1cb3 · outbound

This paper cites Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma

Reference 8

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.238104Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.683089Z digest=sha256:90b2182c601c82a8df6c8fb957728066e058bb30cf995e8400ae437de9099cff

Observation 66df794f-2953-44ef-a089-cce0ffa1d2ea · outbound

This paper cites Fragility index and fragility quotient in randomized clinical trials.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Fragility index and fragility quotient in randomized clinical trials

Reference 9

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.205198Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.748800Z digest=sha256:47cb3eab07ec8987394e8739237e96d9f8ffe1565acf2e0cf6f7879ae3c5dcd8

Observation 746c7c1b-1d1e-4a00-ad94-aa0dfb8e0e98 · outbound

This paper cites The robustness index: going beyond statistical significance by quantifying fragility.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials The robustness index: going beyond statistical significance by quantifying fragility

Reference 10

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.129429Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.795767Z digest=sha256:c3fbb4a9086927944fb7655940479832abb605f6a624b722f65be439c046bcff

Observation 3665090c-961e-4889-b5ca-dbbe337c1383 · outbound

This paper cites A phase ii trial of an alternative schedule of palbociclib and embedded serum tk1 analysis.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials A phase ii trial of an alternative schedule of palbociclib and embedded serum tk1 analysis

Reference 11

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:31.037332Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.823927Z digest=sha256:403f13b1c7afd21926215ae0d8bef4e1555631430814b1aad1a2871446ed9f57

Observation 52029434-9cc8-4f7c-92e0-feff917c52d3 · outbound

This paper cites Assessing and visualizing fragility of clinical results with binary outcomes in r using the fragility package.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Assessing and visualizing fragility of clinical results with binary outcomes in r using the fragility package

Reference 12

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.943988Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.895868Z digest=sha256:64b2c81bf9edaf32bd5a7acd8fd236f4f581911e30ba2cf4e744ad62a94d60b9

Observation bc8e8459-e8d6-4b0a-bf25-b1562167d5c2 · outbound

This paper cites The fragility of phase iii trials in oncology.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials The fragility of phase iii trials in oncology

Reference 13

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.875510Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:29.964683Z digest=sha256:1f123d974ecc941624e377c87a1baed681e69030697988c63145333d5764e52d

Observation d204879b-6669-4d82-8795-cec2034a0b0d · outbound

This paper cites Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Fibrinolysis for patients with intermediate-risk pulmonary embolism

Reference 14

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.816320Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:30.025350Z digest=sha256:b9eda88f63cdad1f62f16c653b4ecc84fbb89c405d150201dcf42d60f6db813a

Observation 6d94f441-1277-4a24-849a-5fbfc8fb59e3 · outbound

This paper cites Statistical fragility of findings from randomized phase 3 trials in pediatric oncology., 2024.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Statistical fragility of findings from randomized phase 3 trials in pediatric oncology., 2024

Reference 15

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.761155Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:30.064247Z digest=sha256:be4a0b68014a06b2174dff9e485f0e55ec751a8b79cf060ab8b64ec98ea254da

Observation b56c7f5f-bc1f-4647-a040-6addc75ca3e0 · outbound

This paper cites Dismantling the fragility index: a demonstration of statistical reasoning.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials Dismantling the fragility index: a demonstration of statistical reasoning

Reference 16

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.703556Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:30.091555Z digest=sha256:a75c70ebd92647c4dcc673a4e730397f1ce7e158f74b910fbdb16e12d6189f57

Observation dbedd8ff-2dfb-439e-a31b-79c07f738ff5 · outbound

This paper cites The fragility index in multicenter randomized controlled critical care trials.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials The fragility index in multicenter randomized controlled critical care trials

Reference 17

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.552735Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:30.131814Z digest=sha256:2b672eba0352762c82e789d253c8fd718316e3ff04ccc6582595f160f79c17d8

Observation aebc3148-634f-4f3d-82f6-0c41fca698f8 · outbound

This paper cites The fragility index in randomized clinical trials as a means of optimizing patient care.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials The fragility index in randomized clinical trials as a means of optimizing patient care

Reference 18

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.444110Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:30.176699Z digest=sha256:cd80ddbf50c185a757819fe7fe7b95d084c0187952a23ad5f1e60db782f56714

Observation fabda033-e096-4896-a8ed-257e3d1f3e45 · outbound

This paper cites The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index.

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index

Reference 19

Resolution
verified fuzzy
raw_fallback, observed 2026-08-12T12:48:30.348769Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

source=arxiv_source observed=2026-08-12T12:48:30.237887Z digest=sha256:cb7b8eb663c82fd8c4ef2cf3d76dc9b222b8eb8ad7044bf1583d73234e963f95

Pith citing papers

No inbound Pith citation observations are available.